4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001209191-21-069350
President & CEO bought 53,634 shares at an average $3.71 ($198,972)
From the SEC's structured data for this filing
Trades in this filing
Quinn Anthony G. · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-09 | Purchase : show line 1 in the form | +43,108 | $3.70 | $159,500 | 318,269 | D |
| 2021-12-10 | Purchase : show line 2 in the form | +10,526 | $3.75 | $39,473 | 328,795 | D |
| Open-market purchases · 53,634 sh · avg $3.71 · $198,972 | ||||||
Loading xslF345X03/doc4.xml…